A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer.

Inge van den Berg,Marcel Smid,Robert R.J. Coebergh van den Braak,Mark A. van de Wiel,Carolien H.M. van Deurzen,Vanja de Weerd,John W. M. Martens,Jan N. M. IJzermans,Saskia M. Wilting

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer.

2021

Inge van den Berg
Marcel Smid
Robert R.J. Coebergh van den Braak
Mark A. van de Wiel
Carolien H.M. van Deurzen
Vanja de Weerd
John W. M. Martens
Jan N. M. IJzermans
Saskia M. Wilting

3545Background: Consensus molecular subtypes (CMSs) can guide precision treatment of colorectal cancer (CRC). Currently available assays can identify CMS1 and CMS4 cases well, while a dedicated tes...

Keywords:

Medicine
Internal medicine
Oncology
Colorectal cancer
in patient
DNA methylation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations